Shingles raises the risk of heart attack, stroke, and other cardiovascular events, with the danger concentrated most heavily in the first year after the rash appears. A systematic review pooling data from multiple studies found that people who developed shingles faced roughly a 30 percent higher chance of stroke and an 18 percent higher chance of heart attack compared to those who did not have the infection. The connection runs deeper than coincidence, involving direct viral damage to blood vessels, widespread inflammation, and even rare but documented cases of the virus attacking the heart muscle itself.
How Large Is the Cardiovascular Risk After Shingles
The most reliable picture of the overall risk comes from pooled analyses of large populations. A meta-analysis published in the Journal of Stroke and Cerebrovascular Diseases found that shingles was linked to an increased risk of stroke or transient ischemic attack, with a relative risk of 1.30, and of heart attack, with a relative risk of 1.18. The stroke risk was highest in the first month after infection and gradually fell over the following months. Subgroup analysis showed that shingles specifically raised the risk of ischemic stroke, the type caused by a blood clot blocking an artery, but not hemorrhagic stroke, the type caused by a bleed.1PubMed. Risk of Stroke/Transient Ischemic Attack or Myocardial Infarction with Herpes Zoster: A Systematic Review and Meta-Analysis
A separate study examining the time course more closely found that stroke risk climbed rapidly in the first twelve months following a shingles diagnosis, reaching an odds ratio of 1.31.2PubMed. Time-varying association between herpes zoster infection and subsequent occurrence of stroke That first year appears to be the window of greatest vulnerability, though some evidence suggests the elevated risk does not fully vanish after twelve months. A case report discussion in the European Heart Journal noted that the risk of a major cardiovascular event may persist for more than twelve years after a shingles episode.3PubMed Central. A case report of shingles and subsequent cardiac ischaemia in a young male
These numbers represent averages across large populations. A 30 percent increase in relative risk does not mean you have a 30 percent chance of having a stroke after shingles. It means your baseline risk, whatever it was before, goes up by about a third. For someone whose baseline risk was already low, the absolute increase remains small. For someone who already had risk factors like high blood pressure, diabetes, or a history of smoking, even a modest relative bump can translate into a meaningful absolute change.
How the Virus Damages Blood Vessels
The varicella zoster virus, the same virus responsible for chickenpox, does not just sit quietly in nerve cells when it reactivates as shingles. It can spread from the nerves into the walls of nearby blood vessels, setting off a chain of damage that researchers call VZV vasculopathy. Studies examining cerebral arteries from patients who died after VZV-related strokes found viral DNA, viral proteins, and actual herpesvirus particles inside the artery walls, proving the virus had been actively replicating there.4The Journal of Infectious Diseases. Varicella Zoster Virus Vasculopathy This is not just an abstract inflammatory response to a distant infection. The virus physically invades arteries and causes direct structural damage.
When the virus infects an artery wall, it triggers local inflammation, thickening of the vessel lining, and disruption of the normal architecture that keeps blood flowing smoothly. The result resembles what happens in atherosclerosis, the slow buildup of plaque, but on a much faster timeline. Inflamed, roughened vessel walls become sticky surfaces where blood clots can form. Those clots can then block blood flow to the brain or heart, causing a stroke or heart attack. A review in The Lancet Neurology described VZV vasculopathies as the product of active, productive virus infection in cerebral arteries, capable of producing a wide range of clinical problems depending on which vessels were involved.5PubMed Central. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment
Beyond direct arterial invasion, shingles also kicks off a body-wide inflammatory response. The immune system floods the bloodstream with signaling molecules that can make blood more prone to clotting, stiffen artery walls, and destabilize existing plaques. Researchers have been investigating exosome biomarkers, tiny packages shed by cells during infection, as a potential way to trace the molecular pathway from shingles reactivation to cerebrovascular events. The underlying mechanisms connecting shingles to these vascular complications are still being mapped in detail.6PubMed Central. Novel discovery of exosomes biomarker from herpes zoster viral infection: linking to cerebrovascular coincidence
When Shingles Appears Near the Eye
Not all shingles episodes carry the same cardiovascular risk. Herpes zoster ophthalmicus, the form of shingles that affects the branch of the trigeminal nerve supplying the forehead and eye, has drawn particular attention from researchers and clinicians. This happens because the trigeminal nerve sits in close anatomical proximity to major cerebral arteries. When the virus reactivates along this nerve, it has a relatively short path to reach the blood vessels feeding the brain.
A case report published in Clinical Practice Cases in Emergency Medicine described a patient who developed an acute ischemic stroke following herpes zoster ophthalmicus and emphasized the critical association between this form of shingles and the increased risk of both stroke and heart attack. The authors recommended that physicians consider close monitoring and cardiovascular risk assessment in patients diagnosed with herpes zoster ophthalmicus, along with clear instructions to return for symptoms that might suggest stroke or blood clots.7PubMed Central. Keeping An Eye Out for Stroke-Herpes Zoster Ophthalmicus Leading to Acute Ischemic Stroke
If you develop a shingles rash on your forehead, around your eye, or on the tip of your nose, that is a red flag that goes beyond the skin and eye complications most people worry about. The proximity to cerebral vasculature makes this particular location a higher-risk scenario for cardiovascular complications, and it warrants a conversation with your doctor about monitoring over the weeks and months that follow.
Shingles Can Directly Affect the Heart Muscle
Most of the cardiovascular risk from shingles comes from the vascular inflammation and clotting problems described above. But in rare cases, the varicella zoster virus can directly infect the heart itself, causing myocarditis, an inflammation of the heart muscle. The connection was first identified back in 1953, and case reports have continued to accumulate over the decades.8PubMed Central. Varicella-Zoster Virus Myocarditis: Early Clinical Diagnosis and Outcome
A recently published case described a 91-year-old woman who developed a typical shingles rash and six days later was hospitalized with clinical, laboratory, and imaging evidence of acute heart failure consistent with myocarditis. The authors described herpes zoster-associated myocarditis as “exceedingly rare and underreported.”9PubMed Central. Myocarditis Associated With Herpes Zoster in a 91-Year-Old Woman: A Rare Cardiac Complication With Favorable Outcomes That last word is important: underreported. Because myocarditis can mimic a heart attack or heart failure from other causes, and because doctors may not connect cardiac symptoms to a shingles episode that seems to be resolving, some cases are likely missed entirely.
Symptoms of myocarditis during or shortly after shingles can include chest pain, shortness of breath, rapid or irregular heartbeat, fatigue, and swelling in the legs. These overlap heavily with the symptoms of a heart attack, which means anyone experiencing them after a recent shingles diagnosis should seek medical attention quickly. The good news from the published cases is that when VZV myocarditis is recognized and treated promptly, outcomes tend to be favorable.
Shingles and Irregular Heart Rhythms
Atrial fibrillation, the most common sustained heart rhythm disorder, also appears to be linked to shingles. A nationwide population-based study in South Korea found that people with severe shingles developed atrial fibrillation at more than twice the rate of people without shingles. Among those with severe cases, the rate was 6.4 per 1,000 person-years compared to 2.7 per 1,000 person-years in the non-shingles group. The elevated risk was concentrated in the first two years after diagnosis; after that window, the difference between groups faded.10PubMed Central. Increased Risk of Atrial Fibrillation in the Early Period after Herpes Zoster Infection: a Nationwide Population-based Case-control Study
Severity mattered in this study. People with mild shingles also had a slightly higher rate of atrial fibrillation than the general population, but the gap was modest. Severe shingles, meaning cases that required hospitalization or involved complications, carried a distinctly higher rhythm risk. The likely explanation ties back to the intensity of the systemic inflammatory response: a more severe infection produces more inflammation, more stress hormones, and more autonomic nervous system disruption, all of which can destabilize heart rhythms.
Atrial fibrillation itself is a major risk factor for stroke because the irregular heartbeat allows blood to pool and form clots in the heart’s upper chambers. This creates a layered risk: shingles can promote stroke through direct vascular damage, through systemic inflammation, and potentially through triggering an arrhythmia that independently raises stroke risk. The pathways are distinct, but they can compound each other.
Younger Patients Face a Surprising Risk Pattern
You might assume that older people, who are more likely to have pre-existing cardiovascular disease, would face the highest additional risk from shingles. The relationship is actually more nuanced. While older adults do develop more cardiovascular events overall, the relative increase in risk from shingles may be proportionally greater in younger people. A case report discussion in the European Heart Journal noted that age and time after shingles infection negatively correlate with cardiovascular complications, meaning that younger patients who develop shingles face a higher likelihood of a subsequent cardiac event than older patients do, relative to their baseline risk.3PubMed Central. A case report of shingles and subsequent cardiac ischaemia in a young male
This may seem counterintuitive, but it makes sense biologically. When a young person develops shingles, it often signals a period of immune stress or an underlying immune vulnerability that you would not expect at their age. The reactivation itself may also be more immunologically disruptive in a younger body that has not previously been primed by decades of chronic low-grade vascular disease. A 35-year-old who develops shingles followed by chest pain is a very different clinical scenario from a 75-year-old with the same sequence, and the younger patient’s event is more likely to be directly attributable to the infection rather than to longstanding risk factors.
This finding has practical implications for doctors and patients alike. A younger person diagnosed with shingles may not think to mention new chest discomfort or neurological symptoms to their physician because they assume those things “don’t happen at my age.” Awareness that shingles genuinely raises cardiovascular risk even in younger adults could lead to earlier recognition and treatment of complications.
Antivirals and Vaccines Can Lower the Risk
The cardiovascular link is not just an academic observation. It has treatment implications. Starting antiviral medication early in a shingles episode appears to reduce the downstream cardiovascular risk. A large cohort study published in Clinical Infectious Diseases found that treatment with antiviral agents was associated with a lower risk of cardiovascular events, with an adjusted hazard ratio of 0.82. Statin use was also independently protective, with a hazard ratio of 0.71.11PubMed. Association Between the Risk for Cardiovascular Events and Antiviral Treatment for Herpes Zoster
Prevention works even better. A study examining over 112,000 patients with shingles found that the recombinant zoster vaccine, Shingrix, reduced cardiovascular disease risk by about 21 percent when given alone. Antiviral therapy alone reduced the risk by about 22 percent. When patients received both the vaccine and antiviral treatment, the risk dropped by roughly 39 percent.12PubMed Central. Protective Effects of Recombinant Zoster Vaccine and Antiviral Therapy Against Cardiovascular Disease Following Herpes Zoster Infection The combination effect suggests that vaccination and antiviral treatment work through partially different pathways, and their benefits stack.
These findings strengthen the case for shingles vaccination beyond its more commonly discussed benefits of preventing the rash and the chronic nerve pain known as postherpetic neuralgia. For people over 50, who are the current target population for the vaccine, cardiovascular protection is an additional reason to get vaccinated. And for anyone actively dealing with a shingles outbreak, the data argues strongly for prompt antiviral treatment, ideally within 72 hours of the rash appearing, not just to limit skin symptoms but to reduce the risk of vascular complications down the road.
What Symptoms to Watch For After Shingles
If you have recently had shingles, being aware of cardiovascular warning signs is worthwhile, especially during the first year. Symptoms worth reporting to your doctor include sudden numbness or weakness on one side of the body, difficulty speaking or understanding speech, sudden severe headache, chest pain or pressure, shortness of breath that is new or worsening, and a heartbeat that feels noticeably fast or irregular. None of these are likely to happen to any individual person after shingles, but the background risk is elevated enough that they should not be dismissed as unrelated.
The risk is highest in the first month and tapers over the following year. People who had severe shingles, shingles affecting the eye area, or shingles that required hospitalization are in a higher-risk subset and should be especially attentive. If you already have cardiovascular risk factors like hypertension, high cholesterol, or diabetes, a shingles episode is a reasonable trigger for reviewing whether those conditions are well controlled. Statin therapy, as the evidence suggests, appears to offer some protection in this context, so it is worth discussing with your doctor if you are not already on one and have other reasons to consider it.
For most people, a shingles episode resolves without cardiac consequences. The virus clears, the inflammation settles, and life returns to normal. But the cardiovascular connection is real, well-documented, and actionable. Prompt antiviral treatment during an outbreak, vaccination before one happens, and attentiveness to warning signs afterward are straightforward steps that meaningfully reduce a risk most people do not know exists.